Montelukast
Product Images NDC 67296-2248

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 67296-2248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

123 (Montelukast Bottle 30)

Montelukast Sodium Tablets USP 10 mg film-coated tablet label from Macleods Pharma USA, showing the NDC 33342-102-07. The label includes dosing information, storage conditions, manufacturer details, and a barcode. The package contains 30 tablets and is intended for adults 15 years and older.*

FDA Label Image

666 (Montelukast Bottle 500)

Montelukast Sodium Tablets USP 10 mg film-coated tablets label from Macleods Pharma USA. The label includes dosage strength (10 mg), storage instructions (20° to 25°C), dispensing instructions for pharmacists, and manufacturer details including Macleods Pharma USA and Macleods Pharmaceuticals Ltd. The label specifies the packaging contains 500 tablets.*

FDA Label Image

444 (Montelukast Bottle 90)

Montelukast Sodium Tablets, USP 10 mg film-coated tablet label from Macleods Pharma USA. The label states the active ingredient amount as Montelukast sodium USP 10.4 mg equivalent to Montelukast 10 mg. It includes dosage storage instructions, manufacturer details, and barcodes. The package size is 90 tablets, and it indicates use for adults 15 years and older.*

FDA Label Image

Montelukast-fig-1 (Montelukast Fig 1)

A line graph depicting mean percent change from baseline over weeks in treatment for two groups: Placebo and Montelukast Sodium. The x-axis represents weeks in treatment from 0 to 15, including a washout period after week 12. The y-axis shows mean percent change from baseline, ranging from 0 to 15. Montelukast Sodium group shows a higher percent change over time compared to placebo, with error bars indicating variability at each time point.*

FDA Label Image

Montelukast-structural (Montelukast Structural)

Chemical structure of the active ingredient montelukast sodium, showing its molecular composition including chlorine, nitrogen, sulfur atoms, and a sodium carboxylate group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.